How to ensure safety factors in the development of artificial heart: Verified by the usage of "modeling and simulation" technology

Mitsuo Umezu

How to ensure safety factors in the development of artificial heart: Verified by the usage of "modeling and simulation" technology

Mitsuo Umezu^*

^*この研究の対応する著者

創造理工学部

研究成果: Conference contribution

1 被引用数 (Scopus)

抄録

The author has involved in two types of clinically available artificial hearts in Japan for these 30 years. Firstly, Toyobo auxiliary pulsatile ventricular assist pump was commercialized in 1991 and over 700 clinical cases are reported in Japanese market. Secondly, an implantable non-pulsatile ventricular assist pump (EVAHEART, Sunmedical Tech. Res. Co.) has been implanted into 11 patients in Japan. The author has been establishing a methodology to eliminate considerable risk factors through a development of hydrodynamic performance test, durability test and biocompatibility test. These in vitro tests are all effective to ensure a safety of the system and also in vitro tests have a contribution to reduce a number of animal experiments.

本文言語	English
ホスト出版物のタイトル	Life System Modeling and Simulation - International Conference, LSMS 2007, Proceedings
ページ	88-96
ページ数	9
出版ステータス	Published - 2007 12月 1
イベント	2007 International Conference on Life System Modeling and Simulation, LSMS 2007 - Shanghai, China 継続期間: 2007 9月 14 → 2007 9月 17

出版物シリーズ

名前	Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)
巻	4689 LNBI
ISSN（印刷版）	0302-9743
ISSN（電子版）	1611-3349

Conference

Conference	2007 International Conference on Life System Modeling and Simulation, LSMS 2007
国/地域	China
City	Shanghai
Period	07/9/14 → 07/9/17

ASJC Scopus subject areas

理論的コンピュータサイエンス
コンピュータサイエンス（全般）

他のファイルとリンク

フィンガープリント

「How to ensure safety factors in the development of artificial heart: Verified by the usage of "modeling and simulation" technology」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

Umezu, M. (2007). How to ensure safety factors in the development of artificial heart: Verified by the usage of "modeling and simulation" technology. In Life System Modeling and Simulation - International Conference, LSMS 2007, Proceedings (pp. 88-96). (Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics); Vol. 4689 LNBI).

How to ensure safety factors in the development of artificial heart: Verified by the usage of "modeling and simulation" technology. / Umezu, Mitsuo.
Life System Modeling and Simulation - International Conference, LSMS 2007, Proceedings. 2007. p. 88-96 (Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics); Vol. 4689 LNBI).

研究成果: Conference contribution

Umezu, M 2007, How to ensure safety factors in the development of artificial heart: Verified by the usage of "modeling and simulation" technology. in Life System Modeling and Simulation - International Conference, LSMS 2007, Proceedings. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics), vol. 4689 LNBI, pp. 88-96, 2007 International Conference on Life System Modeling and Simulation, LSMS 2007, Shanghai, China, 07/9/14.

Umezu M. How to ensure safety factors in the development of artificial heart: Verified by the usage of "modeling and simulation" technology. In Life System Modeling and Simulation - International Conference, LSMS 2007, Proceedings. 2007. p. 88-96. (Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)).

Umezu, Mitsuo. / How to ensure safety factors in the development of artificial heart : Verified by the usage of "modeling and simulation" technology. Life System Modeling and Simulation - International Conference, LSMS 2007, Proceedings. 2007. pp. 88-96 (Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)).

@inproceedings{6a4cc1a8fc0642eabb16eac883d2482d,

title = "How to ensure safety factors in the development of artificial heart: Verified by the usage of {"}modeling and simulation{"} technology",

abstract = "The author has involved in two types of clinically available artificial hearts in Japan for these 30 years. Firstly, Toyobo auxiliary pulsatile ventricular assist pump was commercialized in 1991 and over 700 clinical cases are reported in Japanese market. Secondly, an implantable non-pulsatile ventricular assist pump (EVAHEART, Sunmedical Tech. Res. Co.) has been implanted into 11 patients in Japan. The author has been establishing a methodology to eliminate considerable risk factors through a development of hydrodynamic performance test, durability test and biocompatibility test. These in vitro tests are all effective to ensure a safety of the system and also in vitro tests have a contribution to reduce a number of animal experiments.",

author = "Mitsuo Umezu",

year = "2007",

month = dec,

day = "1",

language = "English",

isbn = "9783540747703",

series = "Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)",

pages = "88--96",

booktitle = "Life System Modeling and Simulation - International Conference, LSMS 2007, Proceedings",

note = "2007 International Conference on Life System Modeling and Simulation, LSMS 2007 ; Conference date: 14-09-2007 Through 17-09-2007",

}

TY - GEN

T1 - How to ensure safety factors in the development of artificial heart

T2 - 2007 International Conference on Life System Modeling and Simulation, LSMS 2007

AU - Umezu, Mitsuo

PY - 2007/12/1

Y1 - 2007/12/1

N2 - The author has involved in two types of clinically available artificial hearts in Japan for these 30 years. Firstly, Toyobo auxiliary pulsatile ventricular assist pump was commercialized in 1991 and over 700 clinical cases are reported in Japanese market. Secondly, an implantable non-pulsatile ventricular assist pump (EVAHEART, Sunmedical Tech. Res. Co.) has been implanted into 11 patients in Japan. The author has been establishing a methodology to eliminate considerable risk factors through a development of hydrodynamic performance test, durability test and biocompatibility test. These in vitro tests are all effective to ensure a safety of the system and also in vitro tests have a contribution to reduce a number of animal experiments.

AB - The author has involved in two types of clinically available artificial hearts in Japan for these 30 years. Firstly, Toyobo auxiliary pulsatile ventricular assist pump was commercialized in 1991 and over 700 clinical cases are reported in Japanese market. Secondly, an implantable non-pulsatile ventricular assist pump (EVAHEART, Sunmedical Tech. Res. Co.) has been implanted into 11 patients in Japan. The author has been establishing a methodology to eliminate considerable risk factors through a development of hydrodynamic performance test, durability test and biocompatibility test. These in vitro tests are all effective to ensure a safety of the system and also in vitro tests have a contribution to reduce a number of animal experiments.

UR - http://www.scopus.com/inward/record.url?scp=38049129742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38049129742&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:38049129742

SN - 9783540747703

T3 - Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)

SP - 88

EP - 96

BT - Life System Modeling and Simulation - International Conference, LSMS 2007, Proceedings

Y2 - 14 September 2007 through 17 September 2007

ER -